Heart Failure and Anemia
NCT00049985 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2009-08-07
Summary
The purpose of this study is to determine whether increasing hemoglobin concentration in patients with heart failure and anemia will improve the patients' functional status, including exercise tolerance and New York Heart Association (NYHA) classification.
Conditions
Interventions
- DRUG
-
Darbepoetin Alfa
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
More Related Trials
-
Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction
NCT05477498 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF
NCT02808585 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
NCT00259038 ·Status: COMPLETED ·Phase: PHASE2
-
Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
NCT04707261 ·Status: RECRUITING ·Phase: PHASE4
-
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
NCT06929806 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies
NCT01798745 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Study of Lipoic Acid on Ischemic Heart Failure
NCT03491969 ·Status: COMPLETED ·Phase: PHASE4
-
Micronutrient Supplementation in Patients With Heart Failure
NCT01005303 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
NCT03030235 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of COR-1 in Heart Failure
NCT01391507 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects
NCT03565328 ·Status: TERMINATED ·Phase: PHASE2
-
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
NCT04363697 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency
NCT03344523 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life
NCT05991128 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction
NCT03098979 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction
NCT02992288 ·Status: COMPLETED ·Phase: PHASE2
-
Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)
NCT01481402 ·Status: COMPLETED ·Phase: NA
-
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
NCT06625307 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
NCT05816265 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction
NCT03281122 ·Status: TERMINATED ·Phase: PHASE1
-
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT00043758 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients
NCT00329485 ·Status: TERMINATED ·Phase: NA
-
Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF
NCT04197635 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product
NCT02804035 ·Status: COMPLETED ·Phase: PHASE2